Picture of GC Cell logo

144510 GC Cell Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap

Annual income statement for GC Cell, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue168,310236,120187,544174,451165,523
Cost of Revenue
Gross Profit68,69896,94855,13533,08928,974
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses131,943191,757183,353242,498411,940
Operating Profit36,36744,3634,191-68,046-246,417
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes39,53336,508-7,464-78,577-271,184
Provision for Income Taxes
Net Income After Taxes30,06425,71579.1-75,737-273,527
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income31,42224,373-174-73,900-272,859
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income31,43124,373-174-73,900-272,859
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS2,8341,77134.3-2,826-8,103
Dividends per Share